Rebecca Taub insider trades: Madrigal Pharmaceuticals (MDGL) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Rebecca reports to the SEC
Open-market buys and sales
15 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 6, 2026 | MDGL | ↓ Sell | 491 | $431.94 | $212K | Direct | Mar 6, 2026 (0d) |
| Jan 26, 2026 | MDGL | ↓ Sell | 647 | $492.42 | $319K | Direct | Jan 26, 2026 (0d) |
| Jan 20, 2026 | MDGL | ↓ Sell | 2,238 | $490.77 | $1.1M | Direct | Jan 20, 2026 (0d) |
| Jan 9, 2026 | MDGL | ↓ Sell | 18,410 | $522.40 | $9.6M | Direct | Jan 13, 2026 (4d) |
| Jan 9, 2026 | MDGL | ↓ Sell | 240 | $550.33 | $132K | Direct | Jan 13, 2026 (4d) |
| Dec 10, 2025 | MDGL | ↓ Sell | 18,650 | $552.15 | $10.3M | Direct | Dec 12, 2025 (2d) |
| Aug 12, 2025 | MDGL | ↓ Sell | 46,463 | $355.32 | $16.5M | Direct | Aug 13, 2025 (1d) |
| Jul 18, 2025 | MDGL | ↓ Sell | 1,000 | $350.00 | $350K | Direct | Jul 22, 2025 (4d) |
| Jul 17, 2025 | MDGL | ↓ Sell | 29,101 | $353.19 | $10.3M | Direct | Jul 18, 2025 (1d) |
| Jan 24, 2025 | MDGL | ↓ Sell | 648 | $335.24 | $217K | Direct | Jan 27, 2025 (3d) |
| Jan 17, 2025 | MDGL | ↓ Sell | 1,689 | $273.41 | $462K | Direct | Jan 17, 2025 (0d) |
| Apr 8, 2024 | MDGL | ↓ Sell | 2,676 | $245.99 | $658K | Direct | Apr 10, 2024 (2d) |
| Apr 5, 2024 | MDGL | ↓ Sell | 73,888 | $243.92 | $18.0M | Direct | Apr 5, 2024 (0d) |
| Jun 11, 2018 | MDGL | ↓ Sell | 73,526 | $287.46 | $21.1M | By SQN, LLC | Jun 12, 2018 (1d) |
| Dec 5, 2008 | VIAP | ↑ Buy | 32,500 | $0.30 | $10K | Direct | Dec 19, 2008 (14d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MDGL insiders
Open-market trades in the last 12 months
About Rebecca Taub's insider trades
Rebecca Taub is a director at Madrigal Pharmaceuticals (MDGL). Since Dec 5, 2008, Rebecca has reported 1 open-market purchase worth $10K and 14 sales worth $89.3M on SEC Form 4. In the last 12 months: 6 sales ($21.7M).
Their filings also include grants and awards (14 filings), option exercises (8 filings), gifts (1 filing), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MDGL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.